Desai Pooja M, Rife Jason P
Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23298-0133, USA.
Arch Biochem Biophys. 2006 May 15;449(1-2):57-63. doi: 10.1016/j.abb.2006.02.028. Epub 2006 Mar 29.
The methyltransferase KsgA modifies two adjacent adenosines in 16S rRNA by adding two methyl groups to the N(6) position of each nucleotide. Unlike nearly all other rRNA modifications, these modifications and the responsible enzyme are highly conserved phylogenetically, suggesting that the modification system has an important role in ribosome biogenesis. It has been known for some time that KsgA recognizes a complex pre-30S substrate in vitro, but there is disagreement in the literature as to what that substrate can be. That disagreement is resolved in this report; KsgA is unable to methylate 30S subunits in the translationally active conformation, but rather can modify 30S when in an experimentally well established translationally inactive conformation. Recent 30S crystal structures provide some basis for explaining why it is impossible for KsgA to methylate 30S in the translationally active conformation. Previous work identified one set of ribosomal proteins important for efficient methylation by KsgA and another set refractory methylation. With the exception of S21 the recent crystal structures of 30S also instructs that the proteins important for KsgA activity all exert their influence indirectly. Unfortunately, S21, which is inhibitory to KsgA activity, has not had its position determined by X-ray crystallography. A reevaluation of published biophysical data on the location also suggests that the refractory nature of S21 is also indirect. Therefore, it appears that KsgA solely senses the conformation 16S rRNA when carrying out its enzymatic activity.
甲基转移酶KsgA通过在16S rRNA中两个相邻腺苷的每个核苷酸的N(6)位置添加两个甲基来修饰它们。与几乎所有其他rRNA修饰不同,这些修饰及其相关酶在系统发育上高度保守,这表明该修饰系统在核糖体生物发生中具有重要作用。一段时间以来人们已知KsgA在体外识别一种复杂的前30S底物,但文献中对于该底物是什么存在分歧。本报告解决了这一分歧;KsgA无法甲基化处于翻译活性构象的30S亚基,而是能够在实验确定的翻译非活性构象下修饰30S。最近的30S晶体结构为解释为什么KsgA不可能在翻译活性构象下甲基化30S提供了一些依据。先前的工作确定了一组对KsgA高效甲基化重要的核糖体蛋白和另一组对甲基化具有抗性的蛋白。除了S21之外,最近的30S晶体结构还表明,对KsgA活性重要的蛋白都是间接发挥其影响的。不幸的是,对KsgA活性具有抑制作用的S21尚未通过X射线晶体学确定其位置。对已发表的关于其位置的生物物理数据的重新评估也表明,S21的抗性本质也是间接的。因此,似乎KsgA在进行其酶促活性时仅感知16S rRNA的构象。